Wasatch Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-312,901
| Closed | -$30.2M | – | 270 |
|
|
2021
Q4 | $30.2M | Sell |
312,901
-33,462
| -10% | -$3.22M | 0.12% | 144 |
|
|
2021
Q3 | $30.1M | Buy |
346,363
+2,572
| +0.7% | +$224K | 0.12% | 141 |
|
|
2021
Q2 | $28.1M | Buy |
343,791
+751
| +0.2% | +$61.5K | 0.11% | 155 |
|
|
2021
Q1 | $32.6M | Sell |
343,040
-1,530,862
| -82% | -$146M | 0.15% | 124 |
|
|
2020
Q4 | $116M | Buy |
1,873,902
+87,610
| +5% | +$5.44M | 0.57% | 65 |
|
|
2020
Q3 | $106M | Buy |
1,786,292
+229,101
| +15% | +$13.6M | 0.68% | 53 |
|
|
2020
Q2 | $109M | Buy |
1,557,191
+451,353
| +41% | +$31.5M | 0.79% | 44 |
|
|
2020
Q1 | $50.2M | Buy |
+1,105,838
| New | +$50.2M | 0.52% | 62 |
|